Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD Protein Inhibitors
Products
Products
Diseases
News
«
1
2
...
16
17
18
19
20
21
22
23
24
25
26
27
28
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
294
588
882
1176
1470
1764
2058
2352
2646
2940
huCD33-BsAb
/ Y-mAbs Therap
humanized CD19 CAR-T cell therapy
/ Shanghai Yake Biotech
iPD1 CD19 eCAR T cell therapy
/ Marino Biotech
iladatuzumab vedotin
(DCDS0780A) / Roche
imneskibart
(AU-007) / Aulos Biosci
inezetamab
(AMG994) / Amgen
itanistomig
(LB101) / Centessa
ivicentamab
(GEN-3009) / Genmab
latikafusp
(AMG 256) / Amgen
linclatamig
(RG6286) / Roche
mRNA-4359
/ Moderna
manelimab
(BCD-135) / Biocad
mavrostobart
(PT199) / Phanes Therap
metuzumab
/ Jiangsu Pacific Meinuoke Biopharmaceutical
mozistobart zoratolimod
(TAC-001) / Tallac Therap
multi-CAR-T cell therapy
/ SZGIMI
murine CD19 CAR-T cell therapy
/ Shanghai Yake Biotech
murine autologous anti-CD19 CART cells
/ Beijing Boren Hospital
nab-paclitaxel/rituximab nanoparticle
(AR160) / Sorrento
nespecabtagene autoleucel
(AT101) / AbClon
obertamig
(JNJ-6358) / J&J
omburtamab I-124
(124I-8H9) / Y-mAbs Therap
onCARlytics
(CF33-CD19) / Imugene
ontorpacept intratumoral
(TTI 621 intratumoral) / Pfizer
pasotuxizumab
(BAY2010112) / Amgen, Bayer
peluntamig
(PT217) / Phanes Therap
podentamig
(MK-4002) / Merck (MSD)
polzastobart
(JTX-8064) / Concentra Biosci
ragistomig
(ABL503) / ABL Bio, I-Mab
reozalimab
(LY3434172) / Eli Lilly
rondecabtagene autoleucel
(LYL314) / Lyell Immunopharma
runimotamab
(RG6194) / Roche
solitomab
(AMG 110) / Amgen
spevatamig
(PT886) / Phanes Therap
tepoditamab
(MCLA-117) / Merus, Gustave Roussy
totrombopag choline
(LGD-4665) / GSK
universal chimeric antigen receptor-modified AT19 cells
/ Wuhan Union Hospital, Chengdu USino Techno
uprevstobart
(INCA00186) / Incyte
urabrelimab
(SRF231) / Coherus Biosci
vepsitamab
(AMG 199) / Amgen
voxalatamab
(JNJ-63898081) / J&J
yttrium Y 90 anti-CD19 Ab
(BU 12) / National Cancer Institute
zaptuzumab-MMAE
(Oba01) / Yantai Obioadc
zeushield cytotoxic T lymphocyte therapy
/ Hunan Yongren Medical Innovation, Hunan Zhaotai Yongren
«
1
2
...
16
17
18
19
20
21
22
23
24
25
26
27
28
